Investing.com -- The European Commission has granted Bristol Myers (NYSE: BMY) Squibb, the biopharmaceutical company based in ...
Bristol Myers Squibb has won European Commission expanded approval of its CAR-T cell therapy Breyanzi in the blood cancer lymphoma.
Despite the fastest drop into correction for the S&P 500 since the pandemic, traders aren’t yet looking to the Federal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback